CA Patent

CA2615855A1 — 4-chromenonyl-1,4-dihydropyridinecarbonitriles and the use thereof

Assigned to Bayer Intellectual Property GmbH · Expires 2007-01-25 · 19y expired

What this patent protects

The invention relates to novel 4-chromenonyl-1,4-dihydropyridinecarbonitriles, to a method for the production thereof, to their use for treating and/or preventing diseases, and to their use for producing medicaments for treating and/or preventing diseases, particularly cardiovasc…

USPTO Abstract

The invention relates to novel 4-chromenonyl-1,4-dihydropyridinecarbonitriles, to a method for the production thereof, to their use for treating and/or preventing diseases, and to their use for producing medicaments for treating and/or preventing diseases, particularly cardiovascular diseases.

Drugs covered by this patent

Patent Metadata

Patent number
CA2615855A1
Jurisdiction
CA
Classification
—
Expires
2007-01-25
Drug substance claim
No
Drug product claim
No
Assignee
Bayer Intellectual Property GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.